Best Radiotherapy for prostate cancer Doctors Worldwide — TOP 41

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Prof. Atalar specializes in MR-Guided Adaptive SRS – an advanced precision radiotherapy technique for prostate cancer, developed during her fellowship at Stanford University.

• 20+ years of radiation oncology experience
• Current President of the Turkish Society for Radiation Oncology
• Honorary Fellow of the American College of Radiology
• Former Chair of Young Turkish Society for Radiation Oncology
• Authored 72 peer-reviewed publications

Dr. Solak specializes in radiotherapy for prostate cancer, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at one of Turkey's top cancer institutes
• Trained at MD Anderson – a global leader in cancer treatment
• Experienced with various cancers including prostate cases
• Works at Hisar Hospital Intercontinental's oncology department

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in complex radiotherapy cases.

• Over 41 years of experience of experience in oncology with a focus on prostate cancer
• Fellowship-trained in sarcoma and brachytherapy at Institut Gustave Roussy
• Associate Professor at Sackler Faculty of Medicine, Tel-Aviv University
• Active member of ESMO and ASCO with numerous research contributions

Dr. Sarid specializes in radiotherapy for prostate cancer at Sourasky Medical Center, with over 38 years of experience of focused oncology experience.

• Trained in cancer urology at Oxford University
• Principal investigator of clinical trials in cancer therapies
• Published 30+ articles on cancer treatment
• Member of The European Society for Medical Oncology

Professor Raimon Miralbell is a world-renowned expert in prostate cancer radiotherapy, collaborating with CERN for advanced treatment research.

• Head of Radiation Oncology at Centro Médico Teknon since 1999
• Specializes in focused radiosurgery techniques like Gammaknife and Cyberknife
• Trained at prestigious institutions including Harvard and Royal Marsden Hospital
• Recipient of the Varian Award for Radiation Oncology
• Published over 100 scientific papers on advanced radiotherapy

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Doctor Sefik Igdem specializes in prostate cancer radiotherapy using advanced Truebeam Stx and Halcyons technology at Gayrettepe Florence Nightingale Hospital.

• Over 30 years of experience of experience in radiation oncology
• Expert in conformal treatments for precise targeting
• Former professor at Demiroğlu Bilim University
• Specializes in head and neck cancers alongside prostate cancer

Head of Radiation Oncology at German Oncology Center – specializes in prostate cancer radiotherapy with extensive clinical experience.

• Doctoral degree from Johann Wolfgang Goethe University
• Over 13 years of experience as senior physician in Radiation Oncology
• Master's in Healthcare Business Studies
• Member of the German Oncology Center team

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Mehmet Dogu Canoglu specializes in advanced radiotherapy techniques at Anadolu Medical Center, a leading facility for prostate cancer treatment.

• Completed radiation oncology training at Kocaeli University
• Expert in MR Linac, CyberKnife, and Varian TrueBeam/Trilogy systems
• Joined Anadolu Medical Center in 2017 after hospital experience across Turkey
• Focuses exclusively on radiation oncology

Phd Viola Fox leads a certified interdisciplinary cancer center, specializing in advanced radiotherapy for prostate cancer.

• Specialized in haematology, oncology, and immunology since 2011
• Chief Physician at BKZ Solingen's cancer center
• Active in molecular biology research for innovative cancer treatments
• Member of German and American oncology societies

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at Malatya State Hospital
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Studied at Selcuk University Faculty of Medicine
• Promoted to Associate Professor in 2016

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Alemdar specializes in medical oncology with a focus on prostate cancer at Medical Park Antalya Hospital Complex.

• Board-certified in medical oncology since 2018
• Extensive experience in internal medicine and oncology
• Practices at a leading hospital complex in Antalya

Dr. Taylan Bükülmez specializes in radiation oncology at Istinye University Liv Hospital Bahcesehir. He focuses on precise radiotherapy for prostate and other cancers.

• Over 15 years of experience at Istinye University Liv Hospital Bahcesehir
• Previously practiced at Akdeniz University Radiation Oncology Clinic
• Trained at Pamukkale University and Akdeniz University
• Specializes in breast, prostate, lung, esophageal, and rectal cancers